294 (PB074) - Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent
| Autor: | Singh, A., Singh, V., Wallis, N., Elimelech, O., Oberman, F., Ramos, A., Yisraeli, J., Spiegelman, V., Sharma, A. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S104-S105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect